Aletia Index
ALETIA INDEX
Clinical assurance for digital health
IndexMethodologyInsightsFor Clinicians
Request Review
IndexMethodologyInsightsFor CliniciansRequest Review
⚠️
This device has not received regulatory clearance
This listing is based on publicly available information and has not been verified by the manufacturer or any regulatory authority.
Index/Pipeline/D'Or Institute for Research and Education
ALT-006184Pre-approval

GUILT-INCREASE-CORRELATION

D'Or Institute for Research and Education · Sponsor

Regulatory Pipeline
✓
Proof of Concept
✓
Development
3
Clinical Trial
4
Pre-submission
5
Submitted
6
Under Review
7
Cleared
All identifiers (2)
Aletia (canonical)ALT-006184
ClinicalTrials.gov (primary)NCT01920490
Trial signal only — manufacturer hasn't claimed this listing yet.
The trial data below was imported from ClinicalTrials.gov. If you represent D'Or Institute for Research and Education, you can claim this listing to add funding, team, and contact details.
Claim this listing →

Clinical Trial Signal

Rebalancing Blame Using fMRI Neurofeedback: a Double-blind Controlled Clinical Proof-of-concept Trial in Remitted Major Depressive Disorder
Phase: na32 enrolledBrazil

Investor Interest

Signal to the team that this device is on your radar. Anonymous — the manufacturer sees the count, not your identity.

0
investors
← Back to Index